>>> US After Hours Summary: XLRN jumps on positive clinical data;

After Hours Summary: XLRN jumps on positive clinical data; FFIV -4% and JNPR -2.2% are lower on disappointing EPS guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CR +4.9%, GGG +4.2%, IBTX +2.3%, BRO +2%, SANM +1%

Companies trading higher in after hours in reaction to news: XLRN +68.1% (Sotatercept achieves primary and secondary endpoints in Phase 2 trial), SURF +13.8% (FDA clears Investigational New Drug applications for its antibody candidates), LAUR +7.6% (to explore strategic alternatives for each of its businesses; reaffirms Q4 guidance)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: FFIV -4%, RMBS -3.2%, JNPR -2.2%, LRN -0.4%, ELS -0.2%, WHR -0.2%

Companies trading lower in after hours in reaction to news: AVH -21.9% (reports monthly metrics), EROS -4.8% (enters into equity investment facility; may elect to sell up to $50 mln of its A ordinary shares), ALEC -2.9% (announces stock offering), GO -2.9% (announces stock offering, reports upside prelim Q4 sales), DNLI -2.4% (files for $150 mln stock offering), ENDP -0.5% (begins shipping authorized generic version of Carafate oral suspension in the US)